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Abstract
Objectives
To assess premedication practices before tracheal intubation of premature newborns in the
delivery room (DR).
Study design
From the national population-based prospective EPIPAGE 2 cohort in 2011, we extracted
all live born preterms intubated in the DR in level-3 centers, without subsequent circulatory
resuscitation. Studied outcomes included the rate and type of premedication, infants’ and
maternities’ characteristics and survival and major neonatal morbidities at discharge from
hospital. Univariate and multivariate analysis were performed and a generalized estimating
equation was used to identify factors associated with premedication use.
Results
Out of 1494 included neonates born in 65 maternities, 76 (5.1%) received a premedication.
Midazolam was the most used drug accounting for 49% of the nine drugs regimens
observed. Premedicated, as compared to non premedicated neonates, had a higher median
[IQR] gestational age (30 [28–31] vs 28 [27–30] weeks, p<10−3), median birth weight (1391
[1037–1767] vs 1074 [840–1440] g, p<10−3) and median 1-minute Apgar score (8 [6–9] vs 6
[3–8], p<10−3). Using univariate analyses, premedication was significantly less frequent
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after maternal general anesthesia and during nighttime and survival without major morbidity
was significantly higher among premedicated neonates (56/73 (81.4%) vs 870/1341
(69.3%), p = 0.028). Only 10 centers used premedication at least once and had characteris-
tics comparable to the 55 other centers. In these 10 centers, premedication rates varied
from 2% to 75%, and multivariate analysis identified gestational age and 1-minute Apgar
score as independent factors associated with premedication use.
Conclusion
Premedication rate before tracheal intubation was only 5.1% in the DR of level-3 maternities
for premature neonates below 34 weeks of gestation in France in 2011 and seemed to be
mainly associated with centers’ local policies.
Introduction
Tracheal intubation is commonly performed in the delivery room (DR) for premature neo-
nates. This procedure is associated with many adverse events such as bradycardia, hypoxia
and increased intracranial pressure [1–4]. Awake intubation is especially associated with
increased intracranial pressure, that can be partially prevented by premedication in neonates
[1, 2]. In the Neonatal Intensive Care Unit (NICU), adverse tracheal intubation–associated
events might be reduced by premedication use, especially paralysis [5]. In addition, an associ-
ation was reported between the number of intubation attempts in the first 4 days of life and
severe intra-ventricular hemorrhage (IVH) [6]. This study’s conclusion speculated that pre-
medication might have a protective effect against IVH, but no evidence was provided. Finally
tracheal intubation is painful [3, 7] but is paradoxically a procedure for which analgosedation
is not systematically administered [7–9]. On the other hand, the transitional period at birth
might expose neonates to a higher risk of adverse drug reactions in case of premedication.
Altogether these observations establish a clinical equipoise concerning the use of premedica-
tion for non-emergent DR intubations. Currently, the American Academy of Pediatrics
(AAP) recommends systematic premedication for neonatal intubation except for “resuscita-
tion in the DR or for life-threatening situations”, based on available evidence and ethical con-
siderations [3]. Those recommendations may theoretically be applied whatever the location
of a patient, if all safety rules are gathered. Nevertheless, no clear guidance is provided for
non-emergent intubations in the DR. This is probably due to the limited data available on the
topic. Indeed, most observational studies on DR intubation did not mention premedication
use [10] or reported a premedication rate ranging from 0% to 26%, varying with gestational
age (GA) categories [5, 6, 11]. However, recent studies demonstrated the feasibility and sug-
gested analgesic efficacy of premedication before DR intubation [12–14]. Considering that
the DR setting was obviously different from the NICU setting, we decided to conduct a spe-
cific study on premedication practices in the DR. The aim of our study was to analyze the
practices of premedication before tracheal intubation of premature infants’ in the DR of
level-3 maternity-units, to describe outcomes before hospital discharge and to identify vari-
ables associated with premedication use at a national level using the French EPIPAGE 2
cohort [15].
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Methods
Study cohort and design
We conducted a retrospective analysis of prospectively collected data from the EPIPAGE 2
study. EPIPAGE 2 is a population-based prospective study that recruited subjects between
March and December 2011 in all the maternity hospitals (levels 1, 2 and 3) in 25 French
regions. This study’s detailed design was previously described [15, 16]. Briefly this cohort
included all infants live born or stillborn and all terminations of pregnancy between 22 and 31
completed weeks of gestation (WG) and a sample of moderate preterm births between 32 and
34 WG. The number of infants required according to the initial sample size calculations was
provided by an 8-month recruitment period for births at 22 through 26 WG, a 6-month period
for 27 through 31 WG, and a 5-weeks period for 32 through 34 WG [16]. Recruitment periods
for births at 22 through 26 weeks occurred between March 28 and December 31 2011; for
births at 27 through 31 weeks between March 28 and October 30 2011; for births at 32 through
34 weeks between March 28 and June 5 2011, with different time windows between regions
[16].
Our study included all live born preterm neonates from level-3 maternity hospital in the
EPIPAGE 2 study who were intubated in the DR. A level-3 maternity hospital in France is
equipped with delivery rooms, dedicated neonatal resuscitation room and neonatal intensive
care unit corresponding to the levels of neonatal care IIIB, IIIC or IIID defined by the AAP,
i.e. allowing perinatal care of all risk profiles and gestational ages, with no restriction on type
or duration of mechanical ventilation. We excluded infants with DR intubations performed in
level 1 and 2 centers, which are less frequent. Intubations in these centers can be performed by
local teams who are not familiar with neonatal intensive care, or by pediatric transportation
teams. We considered that these contexts were particular and might not be comparable to
level-3 centers’ NICUs practices. As some life-threatening situations can contraindicate pre-
medication [3], we excluded infants who received chest compression or epinephrine in the
DR.
Data collection and definitions
A premedication was defined as the use of a sedative and/or an analgesic before any tracheal
intubation. The use of atropine alone was excluded.
At birth and during the neonatal period, data were collected from medical records and
completed by questionnaires filled by obstetrical and neonatal teams. The following neonatal
data available from the EPIPAGE 2 study were used: gender, gestational age at birth, birth
weight, intra-uterine growth restriction based on Olsen’s curves [17], mode of delivery, Apgar
score and management in the delivery room, including tracheal intubation, age at tracheal
intubation, chest compression, epinephrine use and drugs used in the DR. Some data were
unavailable to guarantee anonymisation of included subjects: precise date of birth and conse-
quently week-days, weekends, ferial days or bank holidays. We divided 24 hours in 2 periods:
“day” (8 am-5.59 pm) and “night” (6 pm-7.59 am), corresponding with the on-duty period.
In hospital outcomes included survival, severe intracranial lesions defined as intraventricu-
lar hemorrhage associated with ventricular dilatation (grade III) and intraparenchymal hemor-
rhage (ie, large unilateral parenchymal hyperdensity or a large unilateral porencephalic cyst)
[18] or cystic periventricular leukomalacia (cPVL); stages II and III necrotizing enterocolitis,
according to the staging of Bell et al. [19]; stage 3 or higher retinopathy of prematurity, accord-
ing to the international classification [20] and/or laser treatment; and severe bronchopulmon-
ary dysplasia, defined as administration of oxygen for at least 28 days plus need for 30% or
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more oxygen and/or mechanical ventilatory support or continuous positive airway pressure at
36 weeks’ postmenstrual age [21].
Questionnaires were also distributed to the medical teams of maternities from participating
units to collect data on their structural characteristics, organization and practices. A maternity
unit was considered as performing a premedication if at least one neonate received a premedi-
cation during the study period.
Practices’ description and analysis
We first described the frequency of premedication prior to DR intubation by gestational age
categories and by centers. We then analyzed the drugs or drugs combination used. In order to
identify factors associated with premedication use, we performed univariate analysis in the
whole population including patients’ and centers’ characteristics. Patients-related variables
included in the univariate analysis were perinatal characteristics and the period of birth (day
or night) that was previously reported to be associated with analgesic treatments’ use in the
NICU [22]. We excluded from this analysis all variables that were potentially or certainly pos-
terior to the intubation, such as 5 min Apgar score or exogenous surfactant administration.
Neonatal outcomes at hospital discharge were compared between the premedicated and the
non-premedicated groups using univariate analysis.
Centers-related variables included: total number of births in 2011, location of the DR and
duration of transportation between the DR and the NICU.
Then, within centers that performed at least one premedication, we used multivariate analy-
sis to identify factors derived from the univariate analysis that were independently associated
with premedication use. We excluded from this analysis centers in which premedication was
never performed, considering that this policy was due to the center and not to the patients’
characteristics. Limiting the multivariable analysis to the centers that performed at least one
premedication was thus more appropriate in order to identify specific patients’ characteristics,
independently of the center’s general policy.
Statistical analysis
Descriptive analyses are presented as means (standard deviations), medians (interquartile
ranges), and ranges. Categorical variables are presented as the numbers of individuals (per-
centages) and 95% confidence intervals. Considering the different recruitment periods for
each GA categories, weighting was used to correct disproportional sample sizes and adjust col-
lected data to represent the population from which the sample was drawn. The weighting case
was 0.625, 0.75 and 1 for infants born at 22–26 WG, 27–31 WG and 32–34 WG, respectively.
Considering that infants’ management in each center could be influenced by local policies, a
generalized estimating equation (GEE) model was used for univariate and multivariate analyses,
using each center as the unit of clustering [23]. Variables previously associated in the literature
with premedication use in the NICU [9, 24] or showing an association with a P value<0.20 in
the univariate analyses were included in the model. The results of the GEE model are presented
with their odds ratios, and their 95% confidence intervals (95% CI). Survival and major morbid-
ities at hospital-discharge were compared between groups using Rao–Scott F-adjusted chi-
square test, as exploratory analysis. Statistical significance was set at P<0.05. All statistical analy-
ses were performed with SPSS software (version 17, Chicago, IL) or SAS software (version 9.4).
Ethics
The National Data Protection Authority (CNIL n˚ 911009), the consultative committee on the
treatment of information on personal health data for research purposes (Reference number
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10.626) and the committee for the protection of people participating in biomedical research
(reference CPP SC-2873) approved this study. These 2 committees approved any analysis of
the collected data. The parents of the participants provided their oral consent to participate
in this study. Since this study was observational, according to the French legislation, oral con-
sent to anonymously collect data was obtained from the parents. In case the parents expressed
their opposition to data collection, the neonates were excluded from the study (around 7% of
eligible patients in the main study [15]). The oral agreement to participate in the study was
written in the medical records of the mothers and the newborns included. If the consent was
not obtained or if the patients refused, it was also tracked in the medical charts and the data
were not recorded. The ethics committees approved this consent procedure.
Results
Population
The initial EPIPAGE 2 cohort included 5169 live births. Among the 1937 neonates born in a
level-3 center and intubated in the DR, 1494 (77.1%) were included in the study (Fig 1). The
Fig 1. Population flow chart.
https://doi.org/10.1371/journal.pone.0215150.g001
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166 neonates with missing data on premedication had statistically significantly higher birth
weights and GAs than included infants (1254 g vs 1183 g and 28.9 WG vs 28.5 respectively),
but these differences were clinically irrelevant. Other perinatal characteristics (sex, intra uter-
ine growth restriction, mode of delivery, maternal general anesthesia, one minute Apgar score,
exogenous surfactant in the delivery room, age at intubation and period of birth) were compa-
rable between these 2 populations.
The rate of premedication for tracheal intubation was 5.1% (76/1494): 5/493 (1%) of neo-
nates born between 22 and 26 WG, 67/959 (7%) of those born between 27 and 31 WG and 4/
42 (9.5%) of those between 32 and 34 WG. Distribution of age at tracheal intubation in the pre-
medicated and non-premedicated groups is illustrated in Fig 2. Median [IQR] age at intuba-
tion was significantly lower in the non-premedicated group as compared to the premedicated
group (7 [4–12] vs 35 [20–47] minutes of life respectively; p<0.001). Overall 757/1467 (52%)
of the population received exogenous surfactant in the DR.
Neonates were born in 65 level-3 maternities of which 10 (15.4%) used a premedication
before tracheal intubation in the DR. In these 10 centers, the premedication rate varied from
2.1 to 75.0% (Table 1). Four centers performed 86.8% of all premedications.
Fig 2. Distribution of age (minutes of life) at tracheal intubation in the delivery room according to premedication. Boxes
represent values between the 1st and the 3rd quartile. The bar inside the box denotes median value. The adjacent values are the most
extreme values within 1.5 inter-quartile range of the nearer quartile. All results (except n) are weighted to take into account
differences in the sampling process between gestational age groups.
https://doi.org/10.1371/journal.pone.0215150.g002
Premedication before neonatal tracheal intubation in the delivery room
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Drugs used for premedication
Nine different drugs regimens were used to perform premedication in the DR (Fig 3). In the
76 premedicated neonates, 37 (48.7%) received midazolam, 16 (21.1%) received ketamine, 12
(15.8%) received sufentanil, 11 (14.5%) received morphine, 11 (14.5%) received thiopental and
5 (6.6%) received propofol, alone or in association.
Univariate analysis
Univariate analysis comparing premedicated with non-premedicated neonates is presented in
Table 2. As compared to non-premedicated infants, premedicated infants had higher GA,
birth weight and 1 min Apgar scores; their mother less frequently received general anesthesia.
Table 1. Premedication rates and number of births in 2011 in the 10 centers that performed at least one
premedication.
Maternity units Premedication rate (n premed/n intubations) Number of births in 2011
A 75.0% (15/20) 4125
B 62.5% (20/32) 3426
C 25.9% (15/58) 5039
D 23.9% (16/67) 2989
E 16.7% (1/6) 1633
F 9.1% (2/22) 2805
G 9.1% (2/22) 3131
H 7.7% (3/39) 2346
I 2.2% (1/46) 4824
J 2.1% (1/48) 2725
Total 21.1% (76/360)
https://doi.org/10.1371/journal.pone.0215150.t001
Fig 3. Drug(s) regimens used for premedication before tracheal intubation in the delivery room. The X axis includes all used
premedication regimens with the number of patients in parenthesis. The black bars indicate the percentage of infants who received
each drug or drugs combination within the premedicated group. The corresponding Y-axis is on the left side of the graph. The grey
bars indicate the number of centers that used each drug or drugs combination at least once. The corresponding Y-axis is on the right
side of the graph.
https://doi.org/10.1371/journal.pone.0215150.g003
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Outcomes at discharge from hospital of neonates who received a premedication were com-
parable or better than those who did not, although the occurrence of major neonatal morbidi-
ties was scarse (Table 3).
Univariate analysis also compared the 10 centers which performed a premedication with
the 54 others (1 center did not provide organizational data). All parameters included in the
analysis were comparable (centers with premedication vs no premedication): mean (SD) total
Table 2. Population characteristics and weighted univariate analysis of risk factors associated with premedication use.
Characteristics (n with available data) Total (n = 1494) Weighted univariate analysisa
Premedication (n = 76) No premedication (n = 1418) P-valueb
Sex No. (%) (n = 1494)
Male 803 (53.7) 48 (56.1) 755 (55.3)) 0.860
Female 691 (46.3) 28 (43.9) 663 (44.7)
GA (weeks) (n = 1494)
Mean (SD) 27.8 (2.2) 29.7 (2.1) 28.5 (2.5) <0.01
Median [IQR] 28.0 [26.0–29.0] 30 [28–31] 28 [27–30] <0.01
Range 23–34 25–34 23–34
Birth weight (g) (n = 1494)
Mean (SD) 1070 (362) 1432 (464) 1167 (430) < .001
Median [IQR] 1000 [795–1300] 1391 [1037–1767] 1074 [840–1440] < .001
Range 370–2610 620–2290 370–2610
Mode of delivery “vaginal” (n = 1486), No. (%) 546 (36.7) 20 (69.7) 526 (64.9) 0.280
Maternal general anesthesia (n = 1448), No. (%) 217 (15.0) 7 (7.4) 210 (15.4) 0.016
Intrauterine Growth Restriction (n = 1494), No. (%) 208 (13.9) 9 (9.7) 199 (14.5) 0.136
1 min Apgar score (n = 1462)
Median [IQR] 6 [3–8] 8 [6–9] 6 [3–8] < .001
Range 0–10 1–10 0–10
Exogenous surfactant in the DR (n = 1467), No (%) 757 (51.6) 53 (66.1) 704 (45.8 <0.001
Period of birth “Day” (n = 1439), No. (%) 679 (47.2) 41 (59.7) 638 (48.1) 0.014
a All results (except n) are weighted to take into account differences in the sampling process between GA groups.
b Mann-Whitney’s, t-test or chi square tests for comparisons between premedicated and non-premedicated infants.
https://doi.org/10.1371/journal.pone.0215150.t002
Table 3. Univariate analysis of survival and major neonatal morbidities1 between premedicated and non-premedicated neonates.
Outcomes at hospital discharge a Premedication (n = 76) No premedication (n = 1418) P-value
Survival No (%) 68/76 (91.5) 1200/1418 (87) 0.22
Survival without severe mordidityb No (%) 56/73 (81.4) 870/1341 (69.3) 0.028
Among survivorsb
Severe cerebral lesion No (%) 7/65 (9.1) 80/1189 (6.1) 0.30
Necrotizing enterocolitis No (%) 2/67 (2.1) 44/1186 (3.9) 0.39
Severe bronchopulmonary dysplasia No (%) 1/67 (1.2) 143/1146 (10.1) 0.008
Severe retinopathy of prematurity No (%) 0/59 23/942 0.17
a n are crude and % are weighted
b Denominators are lower than the total number of patients in each group, due to missing data
Severe morbidity was defined as severe bronchopulmonary dysplasia, necrotizing enterocolitis, severe retinopathy of prematurity or any of the following severe cerebral
abnormalities on cranial ultrasonography: intraventricular hemorrhage with ventricular dilatation or intraparenchymal hemorrhage, or cystic periventricular
leukomalacia.
https://doi.org/10.1371/journal.pone.0215150.t003
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number of births in 2011 (3004 (1077) vs 3031 (887), p = 0.390), place of DR and NICU (same
building: 77.8% vs 83.3%, p = 0.650), transportation time between DR and NICU (< 5 min-
utes: 88.9% vs 85.2%, p = 1.000).
Factors associated with premedication in centers where premedication was
used
The multivariate analysis of neonatal factors associated with a premedication across centers
that performed at least one premedication is shown in Table 4. Only GA and 1 minute Apgar
score were significantly associated with the use of premedication in the DR for preterm neo-
nates: neonates between 22 and 26 WG had lower probability to receive a premedication than
late preterm neonates (32–34 WG) (aOR (95% CI), 0.10 (0.03–0.42)), whereas neonates with a
higher 1-minute Apgar score had higher probability to receive premedication (aOR (95% CI),
1.14 (1.05–1.25)) (Table 4).
Discussion
To our knowledge, this is one of the first large descriptive studies to prospectively evaluate pre-
medication before tracheal intubation in the DR for preterm neonates. A premedication was
performed for about 5% of the selected population, in less than 15% of the level-3 maternity
Table 4. Multivariate analysis of neonatal factors associated with a premedication across centers that performed at least one premedication in the DR.
Risk factors (n with available data) No. of
neonates
Crude analysis (n = 360) Multivariate analysis
(n = 335)
Premedicated
(n = 76)
Non-premedicated
(n = 284)
OR (95% CI) P-value Adjusted OR (95%
CI)
P-value
GA categories (weeks)
No. (%) (n = 360)
32–34 13 4 (30.8) 9 (69.2) Reference Reference
27–31 250 67 (26.7) 183 (73.3) 0.82 (0.24–
2.86)
0.760 0.69 (0.20–2.27) 0.519
22–26 97 5 (5.2) 92 (94.8) 0.12 (0.02–
0.66)
0.015 0.10 (0.03–0.42) 0.001
IUGR, No. (%)a (n = 360)
No 318 67 (24.7) 251 (75.3) Reference Reference
Yes 42 9 (16.7) 33 (83.3) 0.84 (0.57–
1.25)
0.389 0.77 (0.37–1.28)
1 min Apgar score b (n = 353) 353 7.3 (2.6) 5.3 (3.0) 1.16 (1.07–
1.26)
< .001 1.14 (1.05–1.25) 0.002
Maternal general anesthesia, No. (%)a
(n = 349)
No 299 68 (25.9) 231 (74.1) Reference Reference
Yes 50 7 (13.0) 43 (87.0) 0.52 (0.18–
1.50)
0.225 0.57 (0.20–1.64) 0.295
Period of birth, No. (%)a (n = 352)
Night 192 32 (17.6) 160 (82.4) Reference Reference
Day 160 41 (29.3) 119 (70.7) 1.64 (0.59–
4.57)
0.349 1.68 (0.57–4.97) 0.347
a n are crude and % are weighted,
b mean (SD) weighted.
Abbreviations: IUGR, intra-uterine growth retardation; OR, odds ratio; CI, confidence interval
https://doi.org/10.1371/journal.pone.0215150.t004
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units and with a large variety of drugs regimens. Survival and severe neonatal morbidity at
hospital discharge were not increased in premedicated infants. Only two patient’s independent
factors, GA and 1 minute Apgar score, were associated with the use of premedication for
intubation.
This 5% premedication rate is much lower than in the two previous declarative studies on
DR intubations performed in France [25, 26]. In these two survey-based questionnaires, the
declared premedication rate was 11% for prophylactic surfactant administration and 20% for
all neonates necessitating tracheal intubation in the DR. The results of an observational study,
conducted in 2 level-3 maternity units in France, showed that 0 to 25% of the neonates intu-
bated in the DR received a specific premedication [11]. In another single-center retrospective
study in the US, 1.1% of infants with birth weight < 1500g who were intubated in the DR
received a premedication [6]. In an international multicenter registry 10% of infants intubated
in the DR were premedicated [5].
In our study, we observed premedication rates varying from 2 to 75% across centers, reveal-
ing a major center effect. Only 10 level-3 maternity units out of 65 performed a premedication
in the DR, 4 of them performing about 87% of all premedications. All compared organizational
factors were similar between the centers that performed a premedication and those that did
not. However, we did not assess the existence of a clinical care team dedicated to the DR or the
intervention of the NICU team in the DR, since both policies exist in France. This variable was
too complex to collect, since organizations often vary within a same center between day- and
night-time, weekdays and holidays. These results may express the prevailing impact of a spe-
cific organization and of a center’s local policy for the practice of a premedication before tra-
cheal intubation in the DR. This is supported by the recent report from the NEAR4NEOS
registry stating that 1 out of 10 academic centers routinely performed premedication before
intubation in the DR [5].
In the present study, at least 6 drugs, alone or in association were used. When confronted to
the recommendations for non-emergent intubation, most of these drugs were not recom-
mended or not described [3]. The choice and the optimal dosing for the sedative and/or anal-
gesic drugs for this procedure are not consensual [3, 27]. Midazolam, which was the most
frequently used drug in our study, should be used in combination with analgesic agents and is
not recommended for premature infants, because of its hypotensive effect [3, 28–31]. We
observed though that it was used alone in nearly 50% of premedications in this study, and only
once associated with sufentanil. Ketamine was the second most frequently used drug in our
study. The use of ketamine is controversial due to its potential apoptotic effects [32, 33], but it
has been successfully used in the DR with a significant decrease in pain scores and no short-
term adverse effect [12]. In a recent study comparing nasal midazolam and nasal ketamine for
neonatal intubation in the DR [14], ketamine was less efficient than midazolam in achieving
rapid and adequate sedation, with a comparable and adequate comfort, assessed by the Face-
less Acute Neonatal pain Scale [34]. Thiopental was most often used in association with mor-
phine, an association that has never been reported, although experience with thiopental exists
[35–37]. Fentanyl, the preferred opioid according to the AAP [3] and the Canadian Paediatric
Society [38] was not used in our study, but sufentanil was the most frequently used short-act-
ing opioid, despite limited data in premature neonates [39]. Propofol, which is a preferred
option [3] was the less frequently used drug, possibly because hypotension was feared [40, 41].
Overall, heterogeneity in centers’ policies and in drugs used denotes the lack of evidence and
underlines the need for research in this field.
In our study, neonates who received a premedication in the DR had a significantly higher
morbidity-free survival rate at hospital discharge than those who were not premedicated after
univariate analysis. However, the imbalance between groups in baseline characteristics
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precludes any firm conclusion, since the number of premedicated patients was too limited to
perform reliable adjustments for confounders through multivariate analysis. This result, com-
bined with others [5, 6], only confirms the current clinical equipoise concerning premedica-
tion use for DR intubation and supports future prospective trials.
Birth weight, maternal general anesthesia, period of birth, 1 minute Apgar score and GA
seemed to be associated with the use of a premedication in univariate analysis. Decreased fre-
quency of premedication in the smallest infants has already been observed in the DR [6]. A
decrease in neonatal motor activity after maternal general anesthesia has been reported in the
first minutes after birth, which is consistent with a decreased use of premedication when
intubation is performed [42], The more frequent use of premedication in the day-time is con-
sistent with the difference for pain management between day and night previously observed
in a large observational study [22]. In the GEE model, GA and 1-minute Apgar score were
the only identified independent factors associated with premedication use in the level-3
maternity units which performed it. The most premature neonates, 22 to 26 WG, were less
likely to receive a premedication than those born after 32 WG, as well as neonates with a low
1-minute Apgar score. The association between GA and premedication use has already been
observed for intubations performed in the NICU [24], although inconstantly [9]. These
results are also consistent with two previous declarative studies conducted in France where
neonates under 28 WG never received a premedication, as those with a low Apgar score
[11, 26].
Although we excluded infants who required chest compression or epinephrine, some
infants might have required intubation as a life-saving procedure because they were not
responding to face-mask ventilation. In this case, avoiding premedication was appropriate
according to the current recommendations [3]. This might have occurred for 30 to 35% of
intubated infants based on previous reports [43, 44]. An alternative approach would have con-
sisted in excluding very early intubations (e.g. before 3 minutes of life), but this might have
inadvertently excluded infants who were rapidly intubated only for the purpose of surfactant
administration, because of local protocols and/or policies and who were in the scope of our
study. On the other hand, around half of intubated infants in our study received surfactant in
the DR. This group probably included premature infants who were intubated for initial stabili-
zation and subsequently treated with surfactant, and extremely premature infants who
received prophylactic surfactant. This was in accordance with most recent European guide-
lines in 2011, issued in 2010, which stated that “prophylaxis should be given to almost all
babies of<26 WG” or “preterm babies with RDS who require intubation for stabilization”
[45]. These infants were not eligible for premedication but their proportion in the whole popu-
lation of surfactant-treated infants was necessarily limited because our study included infants
up to 34 WG. The overall 5% rate of premedication contrasts with high premedication rates in
some centers whose characteristics were similar to those of centers that had lower premedica-
tion rates. This observation underlines the weight of local policies and supports the feasibility
of premedication before DR intubation. The non-premedicated group had a significantly
lower age at intubation compared to the premedicated one (7 vs 35 minutes of life) and under-
went tracheal intubation very soon after birth. The same result was observed in one of the two
observational studies conducted in the DR [11]. This observation can suggest that the non-pre-
medicated babies were the sickest and were not eligible for premedication, whereas time was
allowed for the healthiest neonates to probably be stabilized by non-invasive ventilation while
preparing the premedication. Nevertheless, we cannot rule out that the time required for pre-
medication’s preparation, administration and effect delayed intubation in the premedicated
infants. In a previous observational study in the DR, surfactant administration occurred
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significantly later after ketamine analgesia compared to no analgesia, but 79.5% of the neonates
received surfactant before 30 minutes of life [12]. After nasal midazolam administration, the
median delay between sedation and intubation was about 10 minutes [14].
This study has several limitations as it was not designed to specifically assess premedication
before neonatal tracheal intubation in the DR. Some items are not documented such as the
reason for intubation, the mode of ventilation before tracheal intubation, drugs’ administra-
tion routes and dosage, pain scores, intubation conditions, experience of the operator, num-
ber of attempts, success rate of first attempt and the existence of a specific protocol for
premedication in the DR. We did not explain why such differences for the use of premedica-
tion between French DRs were observed, although some factors were previously identified,
such as operator’s experience [8], the lack of national guidelines and local protocols [11, 26],
no vascular access insertion in the DR [25, 26] or a low compliance to the protocol when avail-
able [9, 11]. Whether premedication use decreases the number of attempts in the DR is impor-
tant in view of the recently reported association between number of intubation attempts and
IVH [6]. In the NICU, some studies found that premedication use decreased the number of
attempts before successful intubation [46, 47], sometimes independently of the operator’s
experience [48]. Future studies on premedication before DR intubation should assess these
aspects.
The strength of this study is its large, exhaustive, population-based design reflecting daily
practice in French level-3 centers. Although prospective trials are essential to guide practice,
such observational studies also provide valuable information on bedside practices and can
inform on the implementation’s chances of randomized trials’ results in daily care. Our results
suggest that the use of analgosedation before DR intubation is tied by the local policies and
willpower of each center rather than their intrinsic factors. Clinical data on the safety and effi-
cacy of available drugs for premedication in the DR are currently too scarce to edit recommen-
dations. However, alleviation of pain and stress during the neonatal period should remain an
essential clinical goal, even in the first minutes of life. This study reinforces the existing clinical
equipoise regarding premedication use before neonatal intubation in the DR and shows that
neonatal mortality and major morbidities are not increased by premedication, which justifies
future clinical trials.
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